On-Demand Webinar

Using Analytics to Uncover Hidden Insights in the COVID-19 Outbreak

This webinar, part of our Analytics in 20 series, will show how analytics techniques like optimization, forecasting and epidemiological modeling can help public health and life sciences companies fight the pandemic.

Cost: Complimentary

About the webinar

What can data tell us about the individuals and businesses affected by the coronavirus outbreak?

If we look at trends over time and apply advanced analytics, can we uncover new insights that will help with future preparedness efforts?

What analytic techniques, such as optimization, forecasting and epidemiological modeling, are most useful for public health and life sciences companies to apply in this situation?

This two-part series will address these questions and more as we take a look at the role analytics plays in supporting critical decisions during a pandemic.

To listen to the first part of this webinar, click here to add it to your calendar. No registration is required.

Have a SAS profile? To complete this form automatically Sign In

*
*
*
 
*
 
*

All personal information will be handled in accordance with the SAS Privacy Statement.

 
  Yes, I would like to receive occasional emails from SAS Institute Inc., its affiliates, and third parties whom SAS has a business relationship with about SAS products and services. I understand that I can withdraw my consent at any time by clicking the opt-out link in the emails.
 
 

About the Experts


Alyssa Farrell, Advisory Industry Marketing Manager, SAS   

Farrell leads industry marketing for the SAS Global Health and Life Sciences Practice. She focuses on the SAS® solutions that help optimize health outcomes for individuals and their communities. She is actively engaged in analyst relations, market research and influencer marketing to stay on top of industry trends and align SAS capabilities to customer needs. Previously at SAS, she has supported the energy and public sector global teams. Prior to joining SAS in 2004, Farrell was a senior consultant in the Deloitte Public Sector practice.


Mark Lambrecht, Director of the Global Health and Life Sciences Practice, SAS

Lambrecht joined SAS in 2005 and now leads a senior team working for SAS’ health care and life sciences industry and organizations. For the past few years, he has been focusing on the impact of digital health and “real-world data” in the converging health care ecosystem. He applies SAS high-performance analytics to generate new insights and improve patient outcomes. His team is bringing SAS’ new health care and life sciences solutions to market and is constantly looking for innovation by identifying customer needs. He talks regularly at conferences about analytics and AI in the age of digital health. He is also interested in fostering data standards and enabling the industry to share and reuse patient data to find new cures and for the benefit of mankind.


Sherrine Eid, Principal Industry Consultant, SAS 

Eid has more than 20 years of experience in real-world evidence, epidemiology and biostatistics. Her passion for better public health led her to work for USAID, CDC and other donors in global health development with a focus on reproductive health and family planning and infectious diseases. Her current focus is supporting regulatory, safety, late-phase and post-marketing activities across therapeutic areas using clinical and real-world data to glean real-world insight.


Atrin Assa, Senior Product Manager, SAS

Assa is responsible for products including SAS Visual Analytics, SAS Drive and SAS Graph Builder. Since joining SAS in 2015, he has helped integrate the SAS Visual Analytics user experience and visual design while weaving AI-powered capabilities throughout the visualization experience. Assa holds a Bachelor of Science in computer science and an MBA in innovation management and marketing from North Carolina State University. His diverse background in marketing, product innovation, product quality and user experience includes work with companies of diverse scales and industries, including Apple, Destineer Studios and Protochips.